Atrial Fibrillation Burden: Assessment, Clinical Significance, and Therapeutic Implications
Life · 21.08.2026 · 16 (8) · 1378
DOI: 10.3390/life16081378 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 21.08.2026. Verfasst von Konstantinos Grigoriou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Medical School, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Greece. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atrial fibrillation (AF) is traditionally classified using categorical clinical patterns and binary recurrence endpoints. However, these measures do not fully reflect arrhythmia frequency, duration, temporal distribution, or progression. AF burden, defined as the proportion of monitored time spent in AF, provides a more granular measure of disease activity and therapeutic response. Recent advances in cardiac implantable electronic devices, insertable cardiac monitors, wearable technologies, and digital platforms have significantly improved burden assessment, although considerable heterogeneity remains in monitoring methods, definitions, and clinically relevant thresholds. This review examines contemporary approaches to AF burden measurement and its associations with thromboembolic risk, heart failure, hospitalization, symptoms, quality of life, disease progression, and mortality. We particularly discuss the reduction of AF burden as a potential therapeutic target following antiarrhythmic drug therapy and catheter ablation, and the limitations of conventional recurrence definitions based on episodes lasting more than 30 s. This review also focuses on the implications for rhythm-control selection, post-ablation monitoring, anticoagulation, and clinical-trial design, while proposing priorities for standardized burden-based assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Medical School, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Greece.
- Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
- First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Medicine, Division of Cardiology, Angiology and Internal Emergency Medicine, Ruhr University Bochum, Knappschaft Kliniken University Hospital Bochum, 44892 Bochum, Germany.
- Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, Harefield Hospital, London UB9 6JH, UK.
- Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
ORCID-Profile: Konstantinos Grigoriou, Nikolaos Ktenopoulos, Panagiotis Theofilis, Panagiotis Iliakis, Panayotis K Vlachakis, Anastasios Apostolos, Antonios P Antoniadis, Nikolaos Fragakis, Paschalis Karakasis
Zitieren
APA
Grigoriou, K., Lamprou, V., Ktenopoulos, N., Theofilis, P., Iliakis, P., Vlachakis, P. K., Apostolos, A., Antoniadis, A. P., Fragakis, N., & Karakasis, P. (2026). Atrial Fibrillation Burden: Assessment, Clinical Significance, and Therapeutic Implications. Life, 16(8), 1378. https://doi.org/10.3390/life16081378
Vancouver
Grigoriou K, Lamprou V, Ktenopoulos N, Theofilis P, Iliakis P, Vlachakis PK, et al. Atrial Fibrillation Burden: Assessment, Clinical Significance, and Therapeutic Implications. Life. 2026;16(8):1378. doi:10.3390/life16081378
BibTeX
@article{Grigoriou2026,
author = {Grigoriou, Konstantinos and Lamprou, Vasileios and Ktenopoulos, Nikolaos and Theofilis, Panagiotis and Iliakis, Panagiotis and Vlachakis, Panayotis K and Apostolos, Anastasios and Antoniadis, Antonios P and Fragakis, Nikolaos and Karakasis, Paschalis},
title = {Atrial Fibrillation Burden: Assessment, Clinical Significance, and Therapeutic Implications},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1378},
doi = {10.3390/life16081378}
}
EUVIMED